NCT01272037 2026-03-18
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
56 trialsNCT01266642 2026-03-11
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT01349322 2026-03-05
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Radiation Therapy Oncology Group
Phase 3 Active not recruiting
NCT02926911 2026-01-27
COMET
Alliance Foundation Trials, LLC.
Phase NA Active not recruiting
NCT03345420 2025-12-30
NOVEMBER
University of Utah
Phase 2 Completed
NCT00556907 2025-11-06
Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast
University of Southern California
Phase NA Terminated
NCT03535506 2025-09-26
WI223281
Georgetown University
Phase 2 Terminated
NCT01841749 2025-09-12
CINNAMOME
Institut Bergonié
Completed
NCT03317405 2025-08-28
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT00769379 2025-06-12
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
National Cancer Institute (NCI)
Phase 3 Completed
NCT01819233 2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA Completed
NCT05086705 2025-04-22
EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT01905046 2025-04-13
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT02993159 2024-12-18
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
Northwestern University
Phase 2 Completed
NCT02876640 2024-06-18
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer
National Cancer Institute (NCI)
Phase 1 Terminated
NCT02636582 2023-12-05
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01556243 2023-11-30
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT02127073 2023-11-09
Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer
Montefiore Medical Center
Phase 2 Terminated
NCT02526498 2023-05-15
TRIUMPH-T
Rutgers, The State University of New Jersey
Phase 2 Completed
NCT02314156 2023-02-22
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Northwestern University
Phase 2 Completed
NCT03775213 2023-01-30
Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)
Duke University
Phase NA Completed
NCT03323658 2023-01-10
Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT01082211 2022-06-21
Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Radiation Therapy Oncology Group
Phase 2 Completed
NCT01961531 2022-03-04
BrUOG 291: Five Fraction Partial Breast Irradiation Using Non-invasive Image-guided Breast Brachytherapy (NIBB)
Brown University
Phase NA Completed
NCT01849250 2021-12-28
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
National Cancer Institute (NCI)
Phase 2 Completed
NCT02137252 2021-11-16
Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT00110136 2021-09-29
St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer
Wake Forest University Health Sciences
Phase 2 Terminated
NCT01448447 2021-07-15
Mammosite ML
Mercy Research
Phase NA Completed
NCT01023477 2021-06-29
Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Inova Health Care Services
Phase 1/2 Completed
NCT00256217 2021-05-11
Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women
University of California, Irvine
Phase 2 Completed
NCT00496808 2020-09-23
Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast
M.D. Anderson Cancer Center
Phase NA Completed
NCT00945061 2020-08-18
Radiation Therapy in Treating Patients With Recurrent Breast Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT01060345 2020-04-09
A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
University of Chicago
Phase 2 Terminated
NCT02961790 2020-01-18
Oxybutynin Chloride in Managing Hot Flashes
Academic and Community Cancer Research United
Phase 3 Completed
NCT01869764 2019-10-30
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT02248662 2019-09-06
Impact of Radiation Therapy on Breast Conservation in DCIS
Dana-Farber Cancer Institute
Completed
NCT02216136 2019-08-02
T:B
Washington University School of Medicine
Completed
NCT00058058 2019-07-16
ACRIN-6667
American College of Radiology Imaging Network
Phase NA Completed
NCT02908178 2019-05-15
Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ
Yale University
Completed
NCT00334542 2019-04-03
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT01194440 2018-09-12
Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00555152 2018-04-20
Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ
National Cancer Institute (NCI)
Phase NA Completed
NCT02365714 2018-04-13
CK-SAPBI
Georgetown University
Phase 1/2 Terminated
NCT00090857 2018-03-30
WISE
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01439711 2018-03-27
Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00290654 2017-12-28
Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT00569166 2017-08-07
Three Different Programs of Paced Breathing in Treating Hot Flashes in Women
Mayo Clinic
Phase NA Completed
NCT00764322 2017-08-01
NRR
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT01754519 2017-07-07
Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery
Roswell Park Cancer Institute
Phase 2 Terminated
NCT01293032 2016-07-12
Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
Virginia Commonwealth University
Phase NA Completed